ATE207498T1 - Neutrophilen inhibitoren aus nematoden - Google Patents

Neutrophilen inhibitoren aus nematoden

Info

Publication number
ATE207498T1
ATE207498T1 AT93911273T AT93911273T ATE207498T1 AT E207498 T1 ATE207498 T1 AT E207498T1 AT 93911273 T AT93911273 T AT 93911273T AT 93911273 T AT93911273 T AT 93911273T AT E207498 T1 ATE207498 T1 AT E207498T1
Authority
AT
Austria
Prior art keywords
nematodes
compositions
neutrophil
neutrophil inhibitors
inhibitors
Prior art date
Application number
AT93911273T
Other languages
English (en)
Inventor
Matthew Moyle
David Lee Foster
George Phillip Vlasuk
Original Assignee
Corvas Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corvas Int Inc filed Critical Corvas Int Inc
Application granted granted Critical
Publication of ATE207498T1 publication Critical patent/ATE207498T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02BINTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00Other engines
    • F02B75/02Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93911273T 1992-05-11 1993-05-11 Neutrophilen inhibitoren aus nematoden ATE207498T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88172192A 1992-05-11 1992-05-11
US99697292A 1992-12-24 1992-12-24
PCT/US1993/004502 WO1993023063A1 (en) 1992-05-11 1993-05-11 Novel neutrophil inhibitors

Publications (1)

Publication Number Publication Date
ATE207498T1 true ATE207498T1 (de) 2001-11-15

Family

ID=27128632

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911273T ATE207498T1 (de) 1992-05-11 1993-05-11 Neutrophilen inhibitoren aus nematoden

Country Status (13)

Country Link
US (1) US6756211B1 (de)
EP (1) EP0731709B1 (de)
JP (1) JP3509860B2 (de)
AT (1) ATE207498T1 (de)
AU (1) AU687737B2 (de)
CA (1) CA2135390A1 (de)
DE (1) DE69331018T2 (de)
DK (1) DK0731709T3 (de)
ES (1) ES2168095T3 (de)
MX (1) MX9302750A (de)
NZ (3) NZ252591A (de)
PT (1) PT731709E (de)
WO (1) WO1993023063A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1749534B1 (de) 1997-12-31 2013-08-21 University Of Iowa Research Foundation Verwendung von parasitären biologischen Wirkstoffen zur Vorbeugung und Kontrolle von chronisch-entzündlichen Darmerkrankungen
EP1186303A3 (de) * 2000-09-06 2003-12-10 Pfizer Products Inc. Ein Neutrophilhemmender Faktor und ein selektive NMDA-NR2B Rezeptor Antagonisten enthaltende Kombinationspräparate zur Behandlung von Schlaganfällen und traumatischen Gehirnschäden
WO2006062776A2 (en) * 2004-11-29 2006-06-15 The Regents Of The University Of California Hydroxyapatite-binding peptides for bone growth and inhibition
DE102007021199B4 (de) * 2006-07-17 2016-02-11 Evonik Degussa Gmbh Zusammensetzungen aus organischem Polymer als Matrix und anorganischen Partikeln als Füllstoff, Verfahren zu deren Herstellung sowie deren Verwendung und damit hergestellte Formkörper
CA2866819C (en) 2012-03-13 2022-01-04 James Cook University Method for treating inflammation
JP2016532456A (ja) 2013-09-18 2016-10-20 ジェームス・クック・ユニバーシティー 改変型抗炎症性タンパク質及び使用方法
EP3554257B1 (de) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Zusammensetzungen und verfahren zur modulation von weissen blutkörperchen oder neutrophilen in einem haustier

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431739A (en) * 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US5019648A (en) * 1987-07-06 1991-05-28 Dana-Farber Cancer Institute Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
DE68923107T2 (de) * 1988-02-26 1996-01-18 Biogen Inc DNA-Sequenzen, rekombinante DNA-Moleküle und Verfahren zur Herstellung von Lipocortin III, IV, V, und VI.
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
JPH05504470A (ja) * 1989-10-20 1993-07-15 ニューイングランド・メディカル・センター・ホスピタルズ・インコーポレーテッド Padgemを介した細胞結合の阻害
US5314992A (en) * 1991-11-25 1994-05-24 Trustees Of Dartmouth College Lipocortin-1 receptor protein and its uses

Also Published As

Publication number Publication date
CA2135390A1 (en) 1993-11-25
NZ505450A (en) 2002-02-01
PT731709E (pt) 2002-04-29
MX9302750A (es) 1994-02-28
JPH07508177A (ja) 1995-09-14
DK0731709T3 (da) 2002-02-11
EP0731709A4 (de) 1997-06-11
WO1993023063A1 (en) 1993-11-25
NZ252591A (en) 1997-02-24
AU687737B2 (en) 1998-03-05
US6756211B1 (en) 2004-06-29
DE69331018D1 (de) 2001-11-29
ES2168095T3 (es) 2002-06-01
AU4246493A (en) 1993-12-13
EP0731709A1 (de) 1996-09-18
DE69331018T2 (de) 2002-06-13
EP0731709B1 (de) 2001-10-24
JP3509860B2 (ja) 2004-03-22
NZ299623A (en) 2000-11-24

Similar Documents

Publication Publication Date Title
CA2129339A1 (en) Inhibitors of thrombosis
GEP20012446B (en) Inhibitors of Interleukin- 1β Converting Enzyme
EP0684830A4 (de) Inhibitoren gegen thrombose.
NO942064L (no) yminhibitorer
BG101841A (bg) Инхибитори на клетъчна адхезия
TR199801168T2 (xx) �nterleukin-1 beta d�n��t�r�c� enzim inhibit�rleri.
ATE318841T1 (de) Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
DE69925508D1 (de) Zelladhäsion- und entzündungshemmende immunosuppressive verbindungen
ATE237342T1 (de) Inhibitoren der leukozytenadhäsion
DK1029921T3 (da) Serpinresistent t-PA, mutanter, gener
KR950700323A (ko) 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE)
FI942625A0 (fi) Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina
ATE261932T1 (de) Inhibitoren der alpha-4 beta-1 vermittelten zelladhäsion
ATE207498T1 (de) Neutrophilen inhibitoren aus nematoden
DE68925032D1 (de) Leukozyten-adhäsions-inhibitor.
FI943511A7 (fi) Pyrroloimidatsolyyli- ja imidatsopyridinyylisubstituoidut 1H-bentsimidatsolijohdannaiset aromataasi-inhibiittoreina
ATE228760T1 (de) Thrombininhibitoren
FI943850A0 (fi) 3-alkyylioksi-, aryylioksi- tai aryylialkyylioksibentso(b)tiofeeni-2-karboksamidit soluadheesion inhibiittoreina
MX9306686A (es) Factor anti-inflamatorio y metodo para su aislamiento.
ATE204478T1 (de) Inhibierung von leukozytenadhäsion
DK0787007T3 (da) Antiinflammatorisk faktor, isoleringsfremgangsmåde og anvendelse
NO954081L (no) Cytotoksisk faktor forbundet med disseminert sklerose, dens påvisning og kvantifisering
DE69332904D1 (de) Hemmung von hiv-infektion
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.
ATE276272T1 (de) Entzündungshemmende peptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee